Market Leader - Peptide Synthesis Market
The global peptide synthesis market is expected to grow at a CAGR of 7.2% during the forecast period. Growth in this market is driven by the increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced automated peptide synthesizers. However, the lack of a unified set of regulations for therapeutic peptides and the high cost of instruments are expected to restrain the growth of this market during the forecast period.
The global peptide synthesis market is a competitive market, with Thermo Fisher Scientific (US), Merck KGaA (Germany), Kaneka Corporation (Japan), GenScript Biotech Corporation (China), and Bachem Holding AG (Switzerland) together accounting for ~30-40% of the global market.
To know about the assumptions considered for the study download the pdf brochure
Thermo Fisher Scientific (US) offers a complete and integrated portfolio of solutions and services for clinical science, laboratory research, and analysis. The company provides products, technologies, and services for protein biology applications, including custom peptide synthesis, through its Biosciences business segment under the Life Sciences Solutions segment. The company has a strong geographic footprint and operates in more than 150 countries across North America, Europe, Latin America, and Asia. The company gained more than USD 12 billion in revenue in 2020 from its Life Sciences Solutions segment, which provides peptide synthesis products and services. In 2021, Thermo Fisher Scientific launched novel capillary chromatography columns for proteomics, clinical peptides, and biopharmaceutical research laboratories. With its strong product portfolio, continuous research and development activities, and broad geographic reach, Thermo Fisher Scientific is expected to grow significantly in the global peptide synthesis market.
Merck KGaA (Germany) has gained a significant share in the peptide synthesis market because of its broad product portfolio, widespread geographical presence, and focus on strategies such as agreements with other companies. Merck provides peptide synthesis products through its Research Solutions subsegment of the Life Science segment. The company primarily focuses on inorganic strategies such as agreements. In 2018, IRBM signed a collaboration agreement with Merck & Co., Inc. (US) to advance peptide therapeutics.
Kaneka Corporation (Japan) operates in the peptide synthesis market through its subsidiary AnaSpec which is a significant player in this market. The company has a strong geographic presence through 102 subsidiaries across North America, Europe, Asia Pacific, Latin America, and Africa. The company has a strong position in the market attributable to its robust products and services portfolio and geographic presence.
GenScript Biotech Corporation (China) is a prominent player in the peptide synthesis market. GenScript provides peptide synthesis products and services under the Life Science Services & Products segment. The company experienced significant growth (~77%) in the revenue of its Life Science Services & Products business segment during 2018-2020. This revenue growth is attributed to the increased demands for life science services and products caused by the outbreak of COVID-19 globally during the first half of 2020, expanded capacity and productivity in customized reagent service, and improvement of online commercial platforms and tools to attract new customers. The company focuses on research and development activities to enhance its offerings in the market. In 2020, its research and development expenses were approximately USD 263.4 million, representing 67% of its total revenue.
Bachem Holding AG (Switzerland) has gained a significant share in the peptide synthesis market. The company offers research products, including catalog products comprising peptides, amino acid derivatives, and biochemicals for peptide research and custom synthesis services. The company has a strong geographical presence. The company invested USD 3.1 million in R&D in 2020.
Related Reports:
Peptide Synthesis Market by Reagent (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid & Recombinant), End User (Pharma, Biotech, CRO) - Global Forecast to 2026
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
